Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Catumaxomab> ?p ?o }
Showing triples 1 to 100 of
100
with 100 triples per page.
- Catumaxomab abstract "Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in patients with metastasizing cancer. It binds to antigens CD3 and EpCAM. It is in clinical trials in the United States currently and is used in Europe. It was developed by Fresenius Biotech and Trion Pharma (Germany).".
- Catumaxomab atcPrefix "L01".
- Catumaxomab atcSuffix "XC09".
- Catumaxomab casNumber "509077-98-9".
- Catumaxomab wikiPageExternalLink www.removab.com.
- Catumaxomab wikiPageID "9042585".
- Catumaxomab wikiPageLength "6522".
- Catumaxomab wikiPageOutDegree "39".
- Catumaxomab wikiPageRevisionID "678400594".
- Catumaxomab wikiPageWikiLink Analgesic.
- Catumaxomab wikiPageWikiLink Analgetic.
- Catumaxomab wikiPageWikiLink Antigen-presenting_cell.
- Catumaxomab wikiPageWikiLink Antipyretic.
- Catumaxomab wikiPageWikiLink Antipyretics.
- Catumaxomab wikiPageWikiLink Ascites.
- Catumaxomab wikiPageWikiLink CD3_(immunology).
- Catumaxomab wikiPageWikiLink Category:Monoclonal_antibodies_for_tumors.
- Catumaxomab wikiPageWikiLink Clinical_trial.
- Catumaxomab wikiPageWikiLink Cytokine.
- Catumaxomab wikiPageWikiLink Cytokines.
- Catumaxomab wikiPageWikiLink Dendritic_cell.
- Catumaxomab wikiPageWikiLink EpCAM.
- Catumaxomab wikiPageWikiLink Epithelial_cell_adhesion_molecule.
- Catumaxomab wikiPageWikiLink Europe.
- Catumaxomab wikiPageWikiLink European_Medicines_Agency.
- Catumaxomab wikiPageWikiLink Fc_receptor.
- Catumaxomab wikiPageWikiLink Fresenius_(company).
- Catumaxomab wikiPageWikiLink Fresenius_SE.
- Catumaxomab wikiPageWikiLink Germany.
- Catumaxomab wikiPageWikiLink Helmholtz_Zentrum_München.
- Catumaxomab wikiPageWikiLink Immunoglobulin_heavy_chain.
- Catumaxomab wikiPageWikiLink Immunoglobulin_light_chain.
- Catumaxomab wikiPageWikiLink Intraperitoneal.
- Catumaxomab wikiPageWikiLink Intraperitoneal_injection.
- Catumaxomab wikiPageWikiLink Macrophage.
- Catumaxomab wikiPageWikiLink Malignancy.
- Catumaxomab wikiPageWikiLink Malignant.
- Catumaxomab wikiPageWikiLink Metastasis.
- Catumaxomab wikiPageWikiLink Monoclonal_antibody.
- Catumaxomab wikiPageWikiLink Mouse.
- Catumaxomab wikiPageWikiLink NSAID.
- Catumaxomab wikiPageWikiLink Natural_killer_cell.
- Catumaxomab wikiPageWikiLink Nausea.
- Catumaxomab wikiPageWikiLink Nonsteroidal_anti-inflammatory_drug.
- Catumaxomab wikiPageWikiLink Peritoneal_cavity.
- Catumaxomab wikiPageWikiLink Peritoneum.
- Catumaxomab wikiPageWikiLink Rat.
- Catumaxomab wikiPageWikiLink T_cell.
- Catumaxomab wikiPageWikiLink T_lymphocyte.
- Catumaxomab wikiPageWikiLink Trifunctional_antibody.
- Catumaxomab wikiPageWikiLink Trion_Pharma.
- Catumaxomab wikiPageWikiLink United_States.
- Catumaxomab wikiPageWikiLink File:Catumaxomab_mechanism.svg.
- Catumaxomab wikiPageWikiLink File:Catumaxomab_structure.svg.
- Catumaxomab wikiPageWikiLinkText "Catumaxomab".
- Catumaxomab wikiPageWikiLinkText "catumaxomab".
- Catumaxomab atcPrefix "L01".
- Catumaxomab atcSuffix "XC09".
- Catumaxomab casNumber "509077".
- Catumaxomab chemspiderid "NA".
- Catumaxomab hasPhotoCollection Catumaxomab.
- Catumaxomab legalStatus "Rx-only".
- Catumaxomab licenceEu "Removab".
- Catumaxomab mabType "3".
- Catumaxomab routesOfAdministration "intraperitoneal infusion".
- Catumaxomab source "axo".
- Catumaxomab target CD3_(immunology).
- Catumaxomab target EpCAM.
- Catumaxomab target Epithelial_cell_adhesion_molecule.
- Catumaxomab tradename "Removab".
- Catumaxomab type "mab".
- Catumaxomab verifiedfields "changed".
- Catumaxomab verifiedrevid "460022109".
- Catumaxomab wikiPageUsesTemplate Template:Drugbox.
- Catumaxomab wikiPageUsesTemplate Template:Extracellular_chemotherapeutic_agents.
- Catumaxomab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Catumaxomab wikiPageUsesTemplate Template:Reflist.
- Catumaxomab subject Category:Monoclonal_antibodies_for_tumors.
- Catumaxomab hypernym Antibody.
- Catumaxomab type Article.
- Catumaxomab type ChemicalSubstance.
- Catumaxomab type Drug.
- Catumaxomab type Antibody.
- Catumaxomab type Article.
- Catumaxomab type Chemical.
- Catumaxomab type Drug.
- Catumaxomab type ChemicalObject.
- Catumaxomab type Thing.
- Catumaxomab type Q8386.
- Catumaxomab comment "Catumaxomab (trade name Removab) is a rat-mouse hybrid monoclonal antibody which is used to treat malignant ascites, a condition occurring in patients with metastasizing cancer. It binds to antigens CD3 and EpCAM. It is in clinical trials in the United States currently and is used in Europe. It was developed by Fresenius Biotech and Trion Pharma (Germany).".
- Catumaxomab label "Catumaxomab".
- Catumaxomab sameAs كاتوماكسوماب.
- Catumaxomab sameAs Catumaxomab.
- Catumaxomab sameAs Catumaxomab.
- Catumaxomab sameAs Katumaksomab.
- Catumaxomab sameAs m.027vn28.
- Catumaxomab sameAs Q408155.
- Catumaxomab sameAs Q408155.
- Catumaxomab wasDerivedFrom Catumaxomab?oldid=678400594.
- Catumaxomab isPrimaryTopicOf Catumaxomab.